Arrowhead Pharmaceuticals Inc. (ARWR)
BMV
Closed
Aug 21, 2026
Day's Range
454.5552 wk Range
454.55Overview - ARWR - Arrowhead Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
1.08T
P/E (Trailing)
‪-45,454.99‬
PEG Ratio
‪-5,727.32‬
Price / Sales (TTM)
‪95.90‬
Price / Book
‪8.13‬
EV / EBITDA
‪-318.93‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.45M
Held by Insiders
‪3.65%‬
Held by Institutions
‪85.57%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪454.55‬
200-Day Avg
‪454.55‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ARWR - Arrowhead Pharmaceuticals Inc.
Peers - ARWR - Arrowhead Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- ARWRBMVArrowhead Pharmaceuticals Inc.64.20BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.33P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.218.20BMarket Cap+4.43%52-week change192.34P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.46P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - ARWR - Arrowhead Pharmaceuticals Inc.
About
Arrowhead Pharmaceuticals is a biotechnology company focused on developing innovative medicines for intractable diseases. The company specializes in RNA interference (RNAi) therapeutics, a cutting-edge approach to treating genetic and metabolic disorders by targeting disease-causing proteins at the molecular level.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
